rs756859037
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 3P and 3B. PM1PP2BP4BP6_Moderate
The NM_001182.5(ALDH7A1):c.1356A>C(p.Lys452Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,613,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001182.5 missense
Scores
Clinical Significance
Conservation
Publications
- pyridoxine-dependent epilepsyInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet, ClinGen
- pyridoxine-dependent epilepsy caused by ALDH7A1 mutantInheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH7A1 | NM_001182.5 | c.1356A>C | p.Lys452Asn | missense_variant | Exon 15 of 18 | ENST00000409134.8 | NP_001173.2 | |
ALDH7A1 | NM_001201377.2 | c.1272A>C | p.Lys424Asn | missense_variant | Exon 15 of 18 | NP_001188306.1 | ||
ALDH7A1 | NM_001202404.2 | c.1164A>C | p.Lys388Asn | missense_variant | Exon 13 of 16 | NP_001189333.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152180Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000677 AC: 17AN: 251236 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461384Hom.: 0 Cov.: 30 AF XY: 0.0000206 AC XY: 15AN XY: 726992 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74342 show subpopulations
ClinVar
Submissions by phenotype
Pyridoxine-dependent epilepsy Benign:1Other:1
Variant interpreted as Uncertain significance and reported on 03-25-2018 by Lab Invitae. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at